ATHE – alterity therapeutics limited - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ATHE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/3

07:10 am

athe

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Medium Report

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Report

2/3

07:10 am

athe

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Medium Report

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Report

2/3

06:15 am

athe

Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark

Medium Report

Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark

Report

2/3

06:15 am

athe

Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark

Medium Report

Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark

Report

1/30

05:49 pm

athe

Rating for ATHE

Medium Report

Rating for ATHE

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.